Dermagnostix offers a comprehensive technological platform for fast and objective molecular diagnostics in dermatology to reduce health care costs and improve patient treatment.

Dermagnostix is a spin-off from the Hahn-Schickard Institut in Freiburg, the Helmholtz Zentrum München (HMGU) and TU München. We are located in Southern Germany (Baden-Wuerttemberg and Bavaria).

Our multidisciplinary team unites expertise in dermatology, basic research, microfluidics and artificial intelligence to bring the most innovative products to market.